Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Profit After Tax: 2013-2025

Historic Profit After Tax for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $8.8 million.

  • Fortress Biotech's Profit After Tax rose 133.07% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.7 million, marking a year-over-year increase of 78.39%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Profit After Tax is $8.8 million, which was down 43.00% from $15.5 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Profit After Tax high stood at $15.5 million for Q2 2025, and its period low was -$68.5 million during Q4 2021.
  • For the 3-year period, Fortress Biotech's Profit After Tax averaged around -$25.0 million, with its median value being -$26.7 million (2024).
  • Its Profit After Tax has fluctuated over the past 5 years, first slumped by 234.35% in 2021, then soared by 153.73% in 2025.
  • Over the past 5 years, Fortress Biotech's Profit After Tax (Quarterly) stood at -$68.5 million in 2021, then increased by 16.15% to -$57.4 million in 2022, then skyrocketed by 49.54% to -$29.0 million in 2023, then rose by 9.21% to -$26.3 million in 2024, then surged by 133.07% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, $15.5 million for Q2 2025, and -$24.7 million during Q1 2025.